A Scoring Model Based on Neutrophil to Lymphocyte Ratio Predicts Recurrence of HBV-Associated Hepatocellular Carcinoma after Liver Transplantation
Open Access
- 26 September 2011
- journal article
- retracted article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 6 (9) , e25295
Abstract
Neutrophil to lymphocyte ratio (NLR) has been proposed to predict prognosis of hepatocellular carcinoma (HCC). However, the cut-off values are empirical. We determined the optimal cut-off value to predict HCC recurrence after liver transplantation (LT) and further established a scoring model based on NLR. We analyzed the outcome of 101 HBV-associated HCC patients undergoing LT. Preoperative risk factors for tumor recurrence were evaluated by univariate analysis. By using ROC analysis, NLR≥3 was considered elevated. The disease-free survival (DFS) and overall survival (OS) for patients with high NLR was significantly worse than that for patients with normal NLR (the 5-year DFS and OS of 28.5% and 19.5% vs. 64.9% and 61.8%, respectively; P5 cm, tumor number >3, macrovascular invasion, AFP≥400 µg/L, NLR≥3, and HBV-DNA level >5 log10 copies/mL were preoperative predictors of DFS. Cox regression analysis showed macrovascular invasion, tumor number, and high NLR were independent prognostic factors. We then established a preoperative prognostic score based on multivariate analysis. Each factor was given a score of 1. Area under the ROC curve of the score was 0.781. All nine patients with score 3 developed recurrence within 6 months after LT. Of 71 patients without vascular invasion, three patients with both tumor number >3 and NLR≥3 developed recurrence within 14 months after LT while the 5-year DFS and OS for patients with a score of 0 or 1 were 68.1% and 62.8%, respectively. Preoperative elevated NLR significantly increases the risk of recurrence in patients underwent LT for HCC. Patients with both NLR≥3 and tumor number >3 are not a good indication for LT. Our score model may aid in the selection of patients that would most benefit from transplantation for HCC.Keywords
This publication has 43 references indexed in Scilit:
- Analysis of Factors Affecting Recurrence of Hepatocellular Carcinoma After Liver Transplantation With a Special Focus on Inflammation MarkersTransplantation, 2011
- Preoperative Neutrophil‐to‐Lymphocyte Ratio (NLR) is Associated with Reduced Disease‐free Survival Following Curative Resection of Pancreatic AdenocarcinomaWorld Journal of Surgery, 2011
- Prognostic Significance of Host‐ and Tumor‐Related Factors in Patients with Gastric CancerWorld Journal of Surgery, 2009
- Targeting Inflammatory Pathways for Prevention and Therapy of Cancer: Short-Term Friend, Long-Term FoeClinical Cancer Research, 2009
- Liver Transplantation for Hepatocellular CarcinomaTransplantation, 2008
- Impact of systemic inflammation on outcome following resection for intrahepatic cholangiocarcinomaJournal of Surgical Oncology, 2008
- Microvascular Invasion in Patients with Hepatocellular Carcinoma and Its Predictable Clinicopathological FactorsAnnals of Surgical Oncology, 2008
- Liver Transplantation Criteria For Hepatocellular Carcinoma Should Be ExpandedAnnals of Surgery, 2007
- Optimizing Staging for Hepatocellular Carcinoma Before Liver Transplantation: A Retrospective Analysis of the Unos/Optn DatabaseLiver Transplantation, 2006
- Tumour lymphocytic infiltrate and recurrence of hepatocellular carcinoma following liver transplantationJournal of Hepatology, 2006